{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:07:45Z","timestamp":1781626065665,"version":"3.54.5"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institutes of Health, United States","award":["R01 NS100779"],"award-info":[{"award-number":["R01 NS100779"]}]},{"name":"National Institutes of Health, United States","award":["R01DK129691"],"award-info":[{"award-number":["R01DK129691"]}]},{"name":"National Institutes of Health, United States","award":["R01 NS140682"],"award-info":[{"award-number":["R01 NS140682"]}]},{"name":"Irma and Norman Braman Endowment"},{"name":"Suzi and Scott Lustgarten Center Endowment"},{"name":"Children\u2019s Hospital of Philadelphia Frontier Program Center for Precision Diagnosis and Therapy for Pediatric Motility Disorders and Frontier Innovative Digital Pathology Imaging Seed funding"},{"name":"Fore Batten Foundation"},{"name":"Children's Brain Diseases Foundation"},{"name":"Institutional support from the Department of Pediatrics, Washington University in St. Louis"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Severe gastrointestinal (GI) symptoms occur in people with CLN3 disease, a neurodegenerative disorder. If left untreated these GI symptoms compromise life quality and may contribute to death. We hypothesized GI symptoms in CLN3 disease are at least partially due to neurodegeneration in the enteric nervous system (ENS), the master regulator of bowel function. We examined the integrity of the ENS in human CLN3 autopsy small bowel and colon, and in CLN3 deficient (\n                    <jats:italic>Cln3<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u0394ex7\/8<\/jats:italic>\n                    <\/jats:sup>\n                    ) mice. We performed detailed immunohistological analyses of enteric neurons and glia and assessed bowel transit times at multiple disease stages. We then tested the therapeutic potential of neonatal intravenous gene therapy (AAV9.hCLN3) to prevent bowel phenotypes in\n                    <jats:italic>Cln3<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u0394ex7\/8<\/jats:italic>\n                    <\/jats:sup>\n                    mice. Human CLN3 bowel displayed a profound loss of enteric neurons and their neurites, with pathological effects upon enteric glia.\n                    <jats:italic>Cln3<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u0394ex7\/8<\/jats:italic>\n                    <\/jats:sup>\n                    mice had normal appearing ENS at 1 month of age, but then experienced progressive loss of both enteric neurons and glia accompanied by marked bowel distention, resembling the human CLN3 phenotype. Degenerative changes in\n                    <jats:italic>Cln3<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u0394ex7\/8<\/jats:italic>\n                    <\/jats:sup>\n                    mouse enteric neurons and glia were largely prevented by systemic neonatal delivery of AAV9.hCLN3 gene therapy, preventing bowel distention at disease endstage. Our findings demonstrate that CLN3 deficiency profoundly damages enteric neurons and glia in both murine and human CLN3 disease, contributing to GI dysfunction. This study provides preclinical evidence that systemic gene therapy may effectively treat multiple aspects of bowel pathology, expanding the therapeutic landscape beyond the CNS.\n                  <\/jats:p>","DOI":"10.1186\/s40478-025-02205-7","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T09:26:37Z","timestamp":1766395597000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Enteric nervous system degeneration in human and murine CLN3 disease, is ameliorated by gene therapy in mice"],"prefix":"10.1186","volume":"13","author":[{"given":"Ewa A.","family":"Zi\u00f3\u0142kowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letitia L.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Eultgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaiprakash","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sardiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca P.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ineka T.","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Sands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert O.","family":"Heuckeroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"2205_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-physiol-021317-121515","volume":"81","author":"S Schneider","year":"2019","unstructured":"Schneider S, Wright CM, Heuckeroth RO (2019) Unexpected roles for the second brain: enteric nervous system as master regulator of bowel function. Annu Rev Physiol 81:235\u2013259","journal-title":"Annu Rev Physiol"},{"key":"2205_CR2","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1152\/physrev.00018.2022","volume":"103","author":"KA Sharkey","year":"2023","unstructured":"Sharkey KA, Mawe GM (2023) The enteric nervous system. Physiol Rev 103:1487\u20131564","journal-title":"Physiol Rev"},{"issue":"1","key":"2205_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1146\/annurev-physiol-022724-105016","volume":"87","author":"J Gonzales","year":"2025","unstructured":"Gonzales J, Gulbransen BD (2025) The physiology of enteric glia. Annu Rev Physiol 87(1):353\u2013380","journal-title":"Annu Rev Physiol"},{"key":"2205_CR4","unstructured":"Windster JD, Kakiailatu NJM, Kuil LE (2024) Human enteric glia diversity in health and disease: new avenues for the treatment of hirschsprung disease. Gastroenterology 24: S0016-5085(24)05803-7"},{"issue":"9","key":"2205_CR5","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3390\/biom14091103","volume":"14","author":"M Lou","year":"2024","unstructured":"Lou M, Heuckeroth RO, Tjaden NEB (2024) Neuroimmune crossroads: the interplay of the enteric nervous system and intestinal macrophages in gut homeostasis and disease. Biomolecules 14(9):1103","journal-title":"Biomolecules"},{"issue":"1","key":"2205_CR6","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1152\/ajpgi.00452.2012","volume":"305","author":"JI Lake","year":"3013","unstructured":"Lake JI, Heuckeroth RO (3013) Enteric nervous system development: migration, differentiation, and disease. Am J Physiol Gastrointest Liver Physiol 305(1):G1\u201324","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5","key":"2205_CR7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/nrgastro.2012.32","volume":"9","author":"JB Furness","year":"2012","unstructured":"Furness JB (2012) The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol 9(5):286\u2013294","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2205_CR8","doi-asserted-by":"publisher","unstructured":"Benthal JT, May-Zhang AA, Southard-Smith EM (2024) Meta-atlas of juvenile and adult enteric neuron scRNA-seq for dataset comparisons and consensus on transcriptomic definitions of enteric neuron Subtypes. BioRxiv [Preprint] 2024.10.31.621315. https:\/\/doi.org\/10.1101\/2024.10.31.621315","DOI":"10.1101\/2024.10.31.621315"},{"issue":"5","key":"2205_CR9","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1053\/j.gastro.2024.12.011","volume":"168","author":"JD Windster","year":"2025","unstructured":"Windster JD, Kakiailatu NJM, Kuil LE (2025) Human enteric glia diversity in health and disease: new avenues for the treatment of hirschsprung disease. Gastroenterology 168(5):965\u2013979e12","journal-title":"Gastroenterology"},{"issue":"4","key":"2205_CR10","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","volume":"99","author":"JF Cryan","year":"2019","unstructured":"Cryan JF, O\u2019Riordan KJ, Cowan CSM (2019) The Microbiota-Gut-Brain axis. Physiol Rev 99(4):1877\u20132013","journal-title":"Physiol Rev"},{"key":"2205_CR11","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neuroscience.2025.03.015","volume":"572","author":"O Hajjeh","year":"2025","unstructured":"Hajjeh O, Rajab I, Bdair M (2025) Enteric nervous system dysfunction as a driver of central nervous system disorders: the forgotten brain in neurological disease. Neuroscience 572:232\u2013247","journal-title":"Neuroscience"},{"key":"2205_CR12","doi-asserted-by":"publisher","first-page":"718220","DOI":"10.3389\/fimmu.2021.718220","volume":"12","author":"B Parodi","year":"2021","unstructured":"Parodi B, Kerlero de Rosbo N (2021) The Gut-Brain axis in multiple Sclerosis. Is its dysfunction a pathological trigger or a consequence of the disease? Front Immunol 12:718220","journal-title":"Front Immunol"},{"issue":"8","key":"2205_CR13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41582-022-00681-2","volume":"18","author":"AH Tan","year":"2022","unstructured":"Tan AH, Lim SY, Lang AE (2022) The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic. Nat Rev Neurol 18(8):476\u2013495","journal-title":"Nat Rev Neurol"},{"key":"2205_CR14","doi-asserted-by":"publisher","first-page":"1579511","DOI":"10.3389\/fnins.2025.1579511","volume":"19","author":"J Doroszkiewicz","year":"2025","unstructured":"Doroszkiewicz J, Winkel I, Mroczko B (2025) Comparative analysis of neuroinflammatory pathways in alzheimer\u2019s disease, parkinson\u2019s disease, and multiple sclerosis: insights into similarities and distinctions. Front Neurosci 19:1579511","journal-title":"Front Neurosci"},{"key":"2205_CR15","first-page":"73","volume":"6","author":"JR Ostergaard","year":"2016","unstructured":"Ostergaard JR (2016) Juvenile neuronal ceroid lipofuscinosis (Batten disease): current insights. Degener Neurol Neuromuscul Dis 6:73\u201383","journal-title":"Degener Neurol Neuromuscul Dis"},{"issue":"4","key":"2205_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s40263-019-00620-8","volume":"33","author":"A Kohlsch\u00fctter","year":"2019","unstructured":"Kohlsch\u00fctter A, Schulz A, Bartsch U (2019) Current and emerging treatment strategies for neuronal ceroid lipofuscinoses. CNS Drugs 33(4):315\u2013325","journal-title":"CNS Drugs"},{"key":"2205_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1474-4422(18)30368-5","volume":"18","author":"SE Mole","year":"2019","unstructured":"Mole SE, Anderson G, Band HA (2019) Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis. Lancet Neurol 18:107\u2013116","journal-title":"Lancet Neurol"},{"key":"2205_CR18","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41582-025-01132-4","volume":"21","author":"EA Zi\u00f3\u0142kowska","year":"2025","unstructured":"Zi\u00f3\u0142kowska EA, Takahashi K, Dickson PI (2025) Neuronal ceroid lipofuscinosis: underlying mechanisms and emerging therapeutic targets. Nat Rev Neurol 21:606\u2013622","journal-title":"Nat Rev Neurol"},{"key":"2205_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.pediatrneurol.2021.04.002","volume":"120","author":"EF Augustine","year":"2021","unstructured":"Augustine EF, Adams HR, de Los Reyes E (2021) Management of CLN1 disease: international clinical consensus. Pediatr Neurol 120:38\u201351","journal-title":"Pediatr Neurol"},{"issue":"1","key":"2205_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13023-021-01813-5","volume":"16","author":"SE Mole","year":"2021","unstructured":"Mole SE, Schulz A, Badoe E (2021) Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients. Orphanet J Rare Dis 16(1):185","journal-title":"Orphanet J Rare Dis"},{"key":"2205_CR21","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/0092-8674(95)90274-0","volume":"82","author":"TJ Lerner","year":"1995","unstructured":"Lerner TJ, Boustany RN, Anderson JW (1995) International Batten disease Consortium. Isolation of a novel gene underlying Batten disease, CLN3. Cell 82:949\u2013957","journal-title":"Cell"},{"issue":"11","key":"2205_CR22","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.bbadis.2012.11.014","volume":"1832","author":"GW Anderson","year":"2013","unstructured":"Anderson GW, Goebel HH, Simonati A (2013) Human pathology in NCL. Biochim Biophys Acta 1832(11):1807\u20131826","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"2205_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1750-3639.2004.tb00077.x","volume":"14","author":"J Tyynel\u00e4","year":"2004","unstructured":"Tyynel\u00e4 J, Cooper JD, Khan MN (2004) Hippocampal pathology in the human neuronal ceroid-lipofuscinoses: distinct patterns of storage deposition, neurodegeneration and glial activation. Brain Pathol 14(4):349\u2013357","journal-title":"Brain Pathol"},{"issue":"2","key":"2205_CR24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s00401-005-0024-x","volume":"111","author":"Y Hachiya","year":"2006","unstructured":"Hachiya Y, Hayashi M, Kumada S (2006) Mechanisms of neurodegeneration in neuronal ceroid-lipofuscinoses. Acta Neuropathol 111(2):168\u2013177","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2205_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.brainres.2004.07.030","volume":"1023","author":"CC Pontikis","year":"2004","unstructured":"Pontikis CC, Cella CV, Parihar N (2004) Late onset neurodegeneration in the Cln3-\/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation. Brain Res 1023(2):231\u2013242","journal-title":"Brain Res"},{"issue":"3","key":"2205_CR26","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.nbd.2005.05.018","volume":"20","author":"CC Pontikis","year":"2005","unstructured":"Pontikis CC, Cotman SL, MacDonald ME (2005) Thalamocortical neuron loss and localized astrocytosis in the Cln3Deltaex7\/8 knock-in mouse model of Batten disease. Neurobiol Dis 20(3):823\u2013836","journal-title":"Neurobiol Dis"},{"key":"2205_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.brainres.2007.05.018","volume":"1162","author":"JM Weimer","year":"2007","unstructured":"Weimer JM, Benedict JW, Elshatory YM (2007) Alterations in striatal dopamine catabolism precede loss of substantia Nigra neurons in a mouse model of juvenile neuronal ceroid lipofuscinosis. Brain Res 1162:98\u2013112","journal-title":"Brain Res"},{"issue":"2","key":"2205_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.nbd.2005.11.008","volume":"22","author":"JM Weimer","year":"2006","unstructured":"Weimer JM, Custer AW, Benedict JW (2006) Visual deficits in a mouse model of Batten disease are the result of optic nerve degeneration and loss of dorsal lateral geniculate thalamic neurons. Neurobiol Dis 22(2):284\u2013293","journal-title":"Neurobiol Dis"},{"key":"2205_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.brainres.2009.02.009","volume":"1266","author":"JM Weimer","year":"2009","unstructured":"Weimer JM, Benedict JW, Getty AL (2009) Cerebellar defects in a mouse model of juvenile neuronal ceroid lipofuscinosis. Brain Res 1266:93\u2013107","journal-title":"Brain Res"},{"key":"2205_CR30","doi-asserted-by":"publisher","first-page":"1061363","DOI":"10.3389\/fneur.2022.1061363","volume":"13","author":"JR Ostergaard","year":"2022","unstructured":"Ostergaard JR, Nelvagal HR, Cooper JD (2022) Top-down and bottom-up propagation of disease in the neuronal ceroid lipofuscinoses. Front Neurol 13:1061363","journal-title":"Front Neurol"},{"issue":"2","key":"2205_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/jnc.12385","volume":"127","author":"J Xiong","year":"2013","unstructured":"Xiong J, Kielian T (2013) Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro-inflammatory phenotype. J Neurochem 127(2):245\u2013258","journal-title":"J Neurochem"},{"issue":"4","key":"2205_CR32","doi-asserted-by":"publisher","first-page":"e95023","DOI":"10.1371\/journal.pone.0095023","volume":"9","author":"M Burkovetskaya","year":"2014","unstructured":"Burkovetskaya M, Karpuk N, Xiong J (2014) Evidence for aberrant astrocyte hemichannel activity in juvenile neuronal ceroid lipofuscinosis (JNCL). PLoS ONE 9(4):e95023","journal-title":"PLoS ONE"},{"issue":"1","key":"2205_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40478-017-0476-y","volume":"5","author":"L Parviainen","year":"2017","unstructured":"Parviainen L, Dihanich S, Anderson GW (2017) Glial cells are functionally impaired in juvenile neuronal ceroid lipofuscinosis and detrimental to neurons. Acta Neuropathol Commun 5(1):74","journal-title":"Acta Neuropathol Commun"},{"key":"2205_CR34","doi-asserted-by":"publisher","first-page":"886567","DOI":"10.3389\/fneur.2022.886567","volume":"13","author":"K Takahashi","year":"2022","unstructured":"Takahashi K, Nelvagal HR, Lange J (2022) Glial dysfunction and its contribution to the pathogenesis of the neuronal ceroid lipofuscinoses. Front Neurol 13:886567","journal-title":"Front Neurol"},{"issue":"22","key":"2205_CR35","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1093\/hmg\/11.22.2709","volume":"11","author":"SL Cotman","year":"2002","unstructured":"Cotman SL, Vrbanac V, Lebel LA (2002) Cln3(Deltaex7\/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth. Hum Mol Genet 11(22):2709\u20132721","journal-title":"Hum Mol Genet"},{"issue":"5","key":"2205_CR36","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.ymthe.2006.01.006","volume":"13","author":"MS Sands","year":"2006","unstructured":"Sands MS, Davidson BL (2006) Gene therapy for lysosomal storage diseases. Mol Ther 13(5):839\u2013849","journal-title":"Mol Ther"},{"issue":"3","key":"2205_CR37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1089\/hum.2012.253","volume":"25","author":"D Sondhi","year":"2014","unstructured":"Sondhi D, Scott EC, Chen A (2014) Partial correction of the CNS lysosomal storage defect in a mouse model of juvenile neuronal ceroid lipofuscinosis by neonatal CNS administration of an adeno-associated virus serotype rh.10 vector expressing the human CLN3 gene. Hum Gene Ther 25(3):223\u2013239","journal-title":"Hum Gene Ther"},{"issue":"37","key":"2205_CR38","doi-asserted-by":"publisher","first-page":"9669","DOI":"10.1523\/JNEUROSCI.1635-16.2016","volume":"36","author":"ME Bosch","year":"2016","unstructured":"Bosch ME, Aldrich A, Fallet R (2016) Self-Complementary AAV9 gene delivery partially corrects pathology associated with juvenile neuronal ceroid lipofuscinosis (CLN3). J Neurosci 36(37):9669\u20139682","journal-title":"J Neurosci"},{"key":"2205_CR39","doi-asserted-by":"publisher","first-page":"1118649","DOI":"10.3389\/fgene.2023.1118649","volume":"14","author":"TB Johnson","year":"2023","unstructured":"Johnson TB, Brudvig JJ, Likhite S (2023) Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 disease. Front Genet 14:1118649","journal-title":"Front Genet"},{"issue":"781","key":"2205_CR40","doi-asserted-by":"publisher","first-page":"eadj1445","DOI":"10.1126\/scitranslmed.adj1445","volume":"17","author":"EA Zi\u00f3\u0142kowska","year":"2025","unstructured":"Zi\u00f3\u0142kowska EA, Jansen MJ, Williams LL (2025) Gene therapy prevents bowel dysmotility, enteric neuron degeneration and extends survival in lysosomal storage disorder mouse models. Sci Transl Med 17(781):eadj1445. https:\/\/doi.org\/10.1126\/scitranslmed.adj1445","journal-title":"Sci Transl Med"},{"issue":"33","key":"2205_CR41","doi-asserted-by":"publisher","first-page":"11543","DOI":"10.1523\/JNEUROSCI.5267-14.2015","volume":"35","author":"M Avetisyan","year":"2015","unstructured":"Avetisyan M, Wang H, Schill EM (2015) Hepatocyte growth factor and MET support mouse enteric nervous system Development, the peristaltic response, and intestinal epithelial proliferation in response to injury. J Neurosci 35(33):11543\u201311558","journal-title":"J Neurosci"},{"issue":"11","key":"2205_CR42","doi-asserted-by":"publisher","first-page":"e124510","DOI":"10.1172\/jci.insight.124510","volume":"5","author":"EM Schill","year":"2019","unstructured":"Schill EM, Wright CM, Jamil A (2019) Down syndrome mouse models have an abnormal enteric nervous system. JCI Insight 5(11):e124510","journal-title":"JCI Insight"},{"issue":"4","key":"2205_CR43","doi-asserted-by":"publisher","first-page":"e131494","DOI":"10.1172\/jci.insight.131494","volume":"5","author":"CM Wright","year":"2020","unstructured":"Wright CM, Garifallou JP, Schneider S (2020) Dlx1\/2 mice have abnormal enteric nervous system function. JCI Insight 5(4):e131494","journal-title":"JCI Insight"},{"issue":"8","key":"2205_CR44","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1053\/j.gastro.2020.02.035","volume":"158","author":"KD Graham","year":"2020","unstructured":"Graham KD, L\u00f3pez SH, Sengupta R (2020) Robust, 3-Dimensional visualization of human colon enteric nervous system without tissue sectioning. Gastroenterology 158(8):2221\u20132235e5. https:\/\/doi.org\/10.1053\/j.gastro.2020.02.035","journal-title":"Gastroenterology"},{"key":"2205_CR45","doi-asserted-by":"publisher","unstructured":"Heuckeroth RO, L\u00f3pez SH, Graham KD (2020) Human colon tissue clearing and immunohistochemistry (protocols.io, 2020). https:\/\/doi.org\/10.17504\/protocols.io.wyeffte","DOI":"10.17504\/protocols.io.wyeffte"},{"issue":"3","key":"2205_CR46","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1053\/j.gastro.2024.02.045","volume":"167","author":"JD Eisenberg","year":"2024","unstructured":"Eisenberg JD, Bradley RP, Graham KD (2024) Three-Dimensional imaging of the enteric nervous system in human pediatric colon reveals new features of hirschsprung\u2019s disease. Gastroenterology 167(3):547\u2013559","journal-title":"Gastroenterology"},{"issue":"2","key":"2205_CR47","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.nbd.2004.03.005","volume":"16","author":"MA Griffey","year":"2004","unstructured":"Griffey MA, Bible E, Vogler C (2004) Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis. Neurobiol Dis 16(2):360\u2013369","journal-title":"Neurobiol Dis"},{"issue":"3","key":"2205_CR48","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ymthe.2005.04.018","volume":"12","author":"M Griffey","year":"2005","unstructured":"Griffey M, Macauley SL, Ogilvie JM (2005) AAV2-mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis. Mol Ther 12(3):413\u2013421","journal-title":"Mol Ther"},{"issue":"3","key":"2205_CR49","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ymthe.2005.11.008","volume":"13","author":"MA Griffey","year":"2006","unstructured":"Griffey MA, Wozniak D, Wong M (2006) CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis. Mol Ther 13(3):538\u2013547","journal-title":"Mol Ther"},{"issue":"6","key":"2205_CR50","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ana.23545","volume":"71","author":"SL Macauley","year":"2012","unstructured":"Macauley SL, Roberts MS, Wong AM (2012) Synergistic effects of central nervous system-directed gene therapy and bone marrow transplantation in the murine model of infantile neuronal ceroid lipofuscinosis. Ann Neurol 71(6):797\u2013804","journal-title":"Ann Neurol"},{"issue":"5","key":"2205_CR51","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s10545-011-9446-x","volume":"35","author":"MS Roberts","year":"2012","unstructured":"Roberts MS, Macauley SL, Wong AM (2012) Combination small molecule PPT1 mimetic and CNS-directed gene therapy as a treatment for infantile neuronal ceroid lipofuscinosis. J Inherit Metab Dis 35(5):847\u2013857","journal-title":"J Inherit Metab Dis"},{"issue":"39","key":"2205_CR52","doi-asserted-by":"publisher","first-page":"13077","DOI":"10.1523\/JNEUROSCI.2518-14.2014","volume":"34","author":"SL Macauley","year":"2014","unstructured":"Macauley SL, Wong AM, Shyng C (2014) An anti-neuroinflammatory that targets dysregulated glia enhances the efficacy of CNS-directed gene therapy in murine infantile neuronal ceroid lipofuscinosis. J Neurosci 34(39):13077\u201313082","journal-title":"J Neurosci"},{"issue":"29","key":"2205_CR53","doi-asserted-by":"publisher","first-page":"E5920","DOI":"10.1073\/pnas.1701832114","volume":"114","author":"C Shyng","year":"2017","unstructured":"Shyng C, Nelvagal HR, Dearborn JT (2017) Synergistic effects of treating the spinal cord and brain in CLN1 disease. Proc Natl Acad Sci U S A 114(29):E5920\u2013E5929","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2205_CR54","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.nbd.2006.09.005","volume":"25","author":"MJ Lim","year":"2007","unstructured":"Lim MJ, Alexander N, Benedict JW (2007) IgG entry and deposition are components of the neuroimmune response in Batten disease. Neurobiol Dis 25(2):239\u2013251","journal-title":"Neurobiol Dis"},{"issue":"1\u20132","key":"2205_CR55","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jneuroim.2010.08.024","volume":"230","author":"SS Seehafer","year":"2011","unstructured":"Seehafer SS, Ramirez-Montealegre D, Wong AM (2011) Immunosuppression alters disease severity in juvenile Batten disease mice. J Neuroimmunol 230(1\u20132):169\u2013172","journal-title":"J Neuroimmunol"},{"issue":"2\u20133","key":"2205_CR56","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.neuropharm.2010.10.010","volume":"60","author":"AD Kov\u00e1cs","year":"2011","unstructured":"Kov\u00e1cs AD, Saje A, Wong A (2011) Temporary Inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten disease. Neuropharmacology 60(2\u20133):405\u2013409","journal-title":"Neuropharmacology"},{"issue":"5","key":"2205_CR57","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.neuropharm.2012.05.040","volume":"63","author":"AD Kov\u00e1cs","year":"2012","unstructured":"Kov\u00e1cs AD, Saje A, Wong A (2012) Age-dependent therapeutic effect of memantine in a mouse model of juvenile Batten disease. Neuropharmacology 63(5):769\u2013775","journal-title":"Neuropharmacology"},{"issue":"6","key":"2205_CR58","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/ana.24815","volume":"80","author":"A Aldrich","year":"2016","unstructured":"Aldrich A, Bosch ME, Fallet R (2016) Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease (CLN3). Ann Neurol 80(6):909\u2013923","journal-title":"Ann Neurol"},{"key":"2205_CR59","doi-asserted-by":"publisher","first-page":"14338","DOI":"10.1038\/ncomms14338","volume":"8","author":"M Palmieri","year":"2017","unstructured":"Palmieri M, Pal R, Nelvagal HR (2017) mTORC1-independent TFEB activation via Akt Inhibition promotes cellular clearance in neurodegenerative storage diseases. Nat Commun 8:14338","journal-title":"Nat Commun"},{"key":"2205_CR60","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3389\/fneur.2019.00963","volume":"10","author":"MA Tarczyluk-Wells","year":"2019","unstructured":"Tarczyluk-Wells MA, Salzlechner C, Najafi AR (2019) Combined Anti-inflammatory and neuroprotective treatments have the potential to impact disease phenotypes in Cln3\u2013\/\u2013 mice. Front Neurol 10:963","journal-title":"Front Neurol"},{"issue":"1","key":"2205_CR61","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s40478-025-02059-z","volume":"23","author":"EA Zi\u00f3\u0142kowska","year":"2025","unstructured":"Zi\u00f3\u0142kowska EA, Jablonka-Shariff A, Williams LL, Jansen MJ, Wang SH (2025) Gene therapy ameliorates neuromuscular pathology in CLN3 disease. Acta Neuropathol Commun 23(1):160","journal-title":"Acta Neuropathol Commun"},{"key":"2205_CR62","doi-asserted-by":"crossref","unstructured":"Rao M, Nelms BD, Dong L (2015) Enteric glia express proteolipid protein 1 and are a transcriptionally unique population of glia in the mammalian nervous system. Glia 2015;63:2040\u20132057","DOI":"10.1002\/glia.22876"},{"issue":"10 Pt B","key":"2205_CR63","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1016\/j.bbadis.2015.05.014","volume":"1852","author":"JD Cooper","year":"2015","unstructured":"Cooper JD, Tarczyluk MA, Nelvagal HR (2015) Towards a new Understanding of NCL pathogenesis. Biochim Biophys Acta 1852(10 Pt B):2256\u20132261","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"2205_CR64","doi-asserted-by":"publisher","first-page":"165570","DOI":"10.1016\/j.bbadis.2019.165570","volume":"1866","author":"HR Nelvagal","year":"2020","unstructured":"Nelvagal HR, Lange J, Takahashi K (2020) Pathomechanisms in the neuronal ceroid lipofuscinoses. Biochim Biophys Acta Mol Basis Dis 1866(9):165570","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"14","key":"2205_CR65","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1212\/WNL.0b013e31821435bd","volume":"76","author":"JR Ostergaard","year":"2011","unstructured":"Ostergaard JR, Rasmussen TB, M\u00f8lgaard H (2011) Neurology. Cardiac involvement in juvenile neuronal ceroid lipofuscinosis (Batten disease). Neurology 76(14):1245\u20131251","journal-title":"Neurology"},{"issue":"9","key":"2205_CR66","doi-asserted-by":"publisher","first-page":"165643","DOI":"10.1016\/j.bbadis.2019.165643","volume":"1866","author":"K Rietdorf","year":"2020","unstructured":"Rietdorf K, Coode EE, Schulz A (2020) Cardiac pathology in neuronal ceroid lipofuscinoses (NCL): more than a Mere co-morbidity. Biochim Biophys Acta Mol Basis Dis 1866(9):165643","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2205_CR67","doi-asserted-by":"publisher","first-page":"1059082","DOI":"10.3389\/fpsyt.2023.1059082","volume":"14","author":"JR Ostergaard","year":"2023","unstructured":"Ostergaard JR (2023) Etiology of anxious and fearful behavior in juvenile neuronal ceroid lipofuscinosis (CLN3 disease). Front Psychiatry 14:1059082","journal-title":"Front Psychiatry"},{"issue":"3","key":"2205_CR68","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/nrgastro.2017.149","volume":"15","author":"RO Heuckeroth","year":"2018","unstructured":"Heuckeroth RO (2018) Hirschsprung disease - integrating basic science and clinical medicine to improve outcomes. Nat Rev Gastroenterol Hepatol 15(3):152\u2013167","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"2205_CR69","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1542\/peds.42.3.483","volume":"42","author":"AS Levine","year":"1968","unstructured":"Levine AS, Lemieux B, Brunning R (1968) Ceroid accumulation in a patient with progressive neurological disease. Pediatrics 42(3):583\u2013591","journal-title":"Pediatrics"},{"issue":"3","key":"2205_CR70","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/brain\/93.3.617","volume":"93","author":"GB Ryan","year":"1970","unstructured":"Ryan GB, Anderson M, Menkes JH (1970) Lipofuscin (ceroid) storage disease of the brain neuropathological and neurochemical studies. Brain 93(3):617\u2013628","journal-title":"Brain"},{"issue":"3","key":"2205_CR71","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0022-510X(73)90076-2","volume":"18","author":"M Haltia","year":"1973","unstructured":"Haltia M, Rapola J, Santavuori P (1973) Infantile type of so-called neuronal ceroid-lipofuscinosis. 2. Morphological and biochemical studies. J Neurol Sci 18(3):269\u2013285","journal-title":"J Neurol Sci"},{"issue":"2","key":"2205_CR72","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/BF00697751","volume":"26","author":"M Haltia","year":"1973","unstructured":"Haltia M, Rapola J, Santavuori P (1973) Infantile type of so-called neuronal ceroid-lipofuscinosis. Histological and electron microscopic studies. Acta Neuropathol 26(2):157\u2013170","journal-title":"Acta Neuropathol"},{"issue":"5837","key":"2205_CR73","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1126\/science.1142658","volume":"317","author":"A Donsante","year":"2007","unstructured":"Donsante A, Miller DG, Li Y (2007) AAV vector integration sites in mouse hepatocellular carcinoma. Science 317(5837):477","journal-title":"Science"},{"issue":"8","key":"2205_CR74","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1016\/j.ymthe.2022.06.004","volume":"30","author":"DE Sabatino","year":"2022","unstructured":"Sabatino DE, Bushman FD, Chandler RJ (2022) Evaluating the state of the science for adeno-associated virus integration: an integrated perspective. Mol Ther 30(8):2646\u20132663","journal-title":"Mol Ther"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02205-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02205-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02205-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:33:56Z","timestamp":1781624036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-025-02205-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2205"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02205-7","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The analysis of de-identified human autopsy material was reviewed by the Institutional Review Board of Washington University School of Medicine in St. Louis, MO and was considered not to meet the definition of human research and therefore exempt from IRB approval. Organ donor colon was from the Gift of Life Donor Program (also Institutional Review Board exempt). All animal procedures were performed in accordance with National Institutes of Health (NIH) guidelines under protocols 2018\u2009\u2212\u20090215 and 21\u20130292 approved by the Institutional Animal Care and Use Committee (IACUC) at Washington University School of Medicine in St. Louis, MO; and The Children\u2019s Hospital of Philadelphia IACUC protocol IAC 22-001041.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JDC has received research support from BioMarin Pharmaceutical Inc., Abeona Therapeutics Inc., REGENXBIO Inc. and Neurogene, and is a consultant for JCR Pharmaceuticals. ROH was a consultant for BlueRock Therapeutics, served on a Scientific Advisory Board for Takeda, and serves on a Scientific Advisory Board for Neurenati Therapeutics. The remaining authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"260"}}